Survey on patients using anticoagulant medications
Phase 4 Study on Clinical History of Patients Who Start a Chronic Anticoagulant Treatment
This study is looking at how well different blood-thinning medications work and their safety for adults who are starting or changing their anticoagulant treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15410 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna, BO) |
| Trial ID | NCT02219984 on ClinicalTrials.gov |
What this trial studies
This observational study collects data on patients who are starting or switching to anticoagulant treatments, including vitamin K antagonists and novel direct oral anticoagulants. It aims to evaluate the efficacy and safety of various anticoagulant therapies and improve understanding of their risks and benefits. Patients aged 18 and older are included if they are beginning anticoagulation therapy or switching from one type of anticoagulant to another, with a minimum expected treatment duration of three months. The study is designed to gather comprehensive clinical histories and treatment patterns over at least one year.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are starting anticoagulant therapy or switching from vitamin K antagonists to other anticoagulants.
Not a fit: Patients under 18 years old or those unwilling to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of anticoagulant therapies, leading to improved treatment strategies for patients with conditions like atrial fibrillation and venous thromboembolism.
How similar studies have performed: Other observational studies have successfully gathered data on anticoagulant therapies, indicating that this approach is supported by previous research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age \>= 18 years Exclusion Criteria: * \< 18 years * not willing to sign informed consent
Where this trial is running
Bologna, BO
- S. Orsola-Malpighi University hospital — Bologna, Bo, Italy (Recruiting)
Study contacts
- Study coordinator: Gualtiero Palareti, MD
- Email: gualtiero.palareti@unibo.it
- Phone: + 328 2279868
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.